Literature DB >> 2604420

Postpubertal gluten challenge in coeliac disease.

M Mäki1, M L Lähdeaho, O Hällström, M Viander, J K Visakorpi.   

Abstract

Altogether 38 postpubertal children with coeliac disease were rebiopsied. Mucosal abnormality in nine (24%) of them indicated poor adherence to the diet. Gluten challenge with a diet containing a normal amount of gluten was performed in those 29 patients with a normal mucosa. During challenge, rebiopsy was done when reticulin antibodies turned positive (mean 0.6 years, range 0.2-2.0) or at the end of the two year study. Histologically a clear relapse into coeliac disease was seen in all 23 patients who were positive for reticulin antibodies. At this time gliadin antibodies were positive in all but two. Sixteen (70%) of those who relapsed were completely asymptomatic. Three girls and one boy did not relapse within two years, indicating the possible recovery from coeliac disease to be 11%. All four had undergone gluten challenge earlier in childhood, after initial diagnosis and mucosal recovery, and this had resulted in mucosal relapse. To establish definite postpubertal recovery from coeliac disease in cases with normal mucosa at two years from challenge, further follow up studies of reticulin antibodies and later rebiopsy are needed. The reticulin antibody test seems to be suitable for prediction of mucosal relapse in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2604420      PMCID: PMC1792633          DOI: 10.1136/adc.64.11.1604

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  The teenage coeliac: follow up study of 102 patients.

Authors:  P J Kumar; J Walker-Smith; P Milla; G Harris; J Colyer; R Halliday
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

2.  Types of 'reticulin' antibodies detected in human sera by immunofluorescence.

Authors:  M Rizzetto; D Doniach
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

3.  Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79.

Authors:  R F Logan; G Tucker; E A Rifkind; R C Heading; A Ferguson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

4.  Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay.

Authors:  E Vainio; K Kalimo; T Reunala; M Viander; T Palosuo
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

5.  Is coeliac disease underdiagnosed?

Authors:  C M Swinson; A J Levi
Journal:  Br Med J       Date:  1980-11-08

6.  Reintroduction of gluten in adults and children with treated coeliac disease.

Authors:  P J Kumar; D P O'Donoghue; K Stenson; A M Dawson
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

7.  Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease.

Authors:  M Mäki; O Hällström; T Vesikari; J K Visakorpi
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

8.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

9.  The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN).

Authors:  A S McNeish; H K Harms; J Rey; D H Shmerling; J K Visakorpi; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1979-10       Impact factor: 3.791

10.  Possible role for a human adenovirus in the pathogenesis of celiac disease.

Authors:  M F Kagnoff; R K Austin; J J Hubert; J E Bernardin; D D Kasarda
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  14 in total

1.  Local challenge of oral mucosa with gliadin in patients with coeliac disease.

Authors:  H Lähteenoja; M Mäki; M Viander; A Toivanen; S Syrjänen
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  Is an intestinal permeability test a valid marker for slight dietary transgressions in adolescents with coeliac disease?

Authors:  P Fernández-Calle; R Codoceo; I Polanco; J Gómez-Cerezo; M Orsi; J M Tenias
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

4.  Normal small bowel biopsy followed by coeliac disease.

Authors:  M Mäki; K Holm; S Koskimies; O Hällström; J K Visakorpi
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

5.  Lack of cellular and humoral immunological responses to oats in adults with coeliac disease.

Authors:  E K Janatuinen; T A Kemppainen; P H Pikkarainen; K H Holm; V M Kosma; M I Uusitupa; M Mäki; R J Julkunen
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.

Authors:  Tamara Matysiak-Budnik; Georgia Malamut; Natacha Patey-Mariaud de Serre; Etienne Grosdidier; Sylvie Seguier; Nicole Brousse; Sophie Caillat-Zucman; Nadine Cerf-Bensussan; Jacques Schmitz; Christophe Cellier
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

7.  Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet.

Authors:  T Kutlu; N Brousse; C Rambaud; F Le Deist; J Schmitz; N Cerf-Bensussan
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

8.  Antigliadin and antiendomysium antibody determination for coeliac disease.

Authors:  A Bürgin-Wolff; H Gaze; F Hadziselimovic; H Huber; M J Lentze; D Nusslé; C Reymond-Berthet
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

9.  Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.

Authors:  Marja-Leena Lähdeaho; Markku Mäki; Kaija Laurila; Heini Huhtala; Katri Kaukinen
Journal:  BMC Gastroenterol       Date:  2011-11-24       Impact factor: 3.067

Review 10.  The clinical response to gluten challenge: a review of the literature.

Authors:  Maaike J Bruins
Journal:  Nutrients       Date:  2013-11-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.